v3.25.2
Net Loss per Share (Tables)
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Net Loss Per Share, Basic and Diluted
The following data shows the amounts used in computing net loss per share and the effect on net loss and the weighted-average number of shares as follows:
Three Months Ended June 30,Six Months Ended June 30,
(in thousands, except share and per share amounts)2025202420252024
Net loss$(124,676)$(108,685)$(134,954)$(156,902)
Weighted average shares used in computing net loss per share of Class A and B Common Stock:
Basic103,712,230 8,778,200 89,804,391 5,334,380 
Diluted103,712,230 8,778,200 89,804,391 5,334,380 
Net loss per share of Class A and B Common Stock attributable to common stockholders:
Basic$(1.20)$(12.38)$(1.50)$(29.41)
Diluted$(1.20)$(12.38)$(1.50)$(29.41)
Schedule of Antidilutive Shares Excluded From Calculation of Diluted Net Loss Per Share
The table below presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock attributable to Common Stock stockholders due to their antidilutive effect:
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Shares issuable upon conversion of SPA Portfolio Notes36,433,104 4,303,458 36,433,104 4,303,458 
Shares issuable upon conversion of Unsecured Convertible Notes53,640 897,756 53,640 897,756 
Shares issuable upon exercise of equity classified SPA Portfolio Note warrants15,433 14,218 15,433 14,218 
Shares issuable upon exercise of liability classified SPA Portfolio Note warrants56,478,903 — 56,478,903 — 
Other warrants5,776,657 228,482 5,776,657 228,482 
Stock-based compensation awards – Options2,327 2,465 2,327 2,465 
Stock-based compensation awards – RSUs148,241 13,842 148,241 13,842 
Public warrants2,453 2,452 2,453 2,452 
Private warrants12 12 12 12 
98,910,770 5,462,685 98,910,770 5,462,685